Latest Anemia News
Clues to Spontaneous Resolution of Anemia in Hemodialysis Found
Restoration of iron homeostasis and normal hepcidin levels appears to play a key role in freeing hemodialysis patients from having to receive erythropoiesis-stimulating agents.
Anemia Severity Linked to LVH Risk in Pediatric Dialysis
Time-averaged hemoglobin levels, not hemoglobin cycling, is associated with an increased risk of left ventricular hypertrophy in pediatric dialysis patients, a study found.
Study: Long-Term Darbepoetin Use Safe, Effective in Non-Dialysis CKD
Japanese post-marketing study identified no new safety concerns among patients with non-dialysis chronic kidney disease treated with darbepoetin alfa and followed up for 3 years.
Gastrointestinal Lesions Common in Patients With CKD Anemia
In a Spanish study, endoscopic evaluation of patients with CKD and anemia revealed that 68.2% of patients had at least 1 gastrointestinal lesion.
Obese HD Patients Need Less Erythropoietin to Treat Anemia
New study "adds to the evidence of obesity-associated advantages," researchers conclude.
Intermittent IV Iron Infusion May Be Better for HD Patients
In a small study, intermittent vs continuous administration of IV iron resulted in less hemoglobin variability in hemodialysis patients with anemia.
ESA Biosimilar Effective for Anemia in Hemodialysis Patients
Researchers found "no clinically meaningful differences" in efficacy and safety between the biosimilar epoetin alfa-epbx and epoetin alfa.
Pre-Dialysis Anemia Ups Mortality After Dialysis Start
Patients with vs without anemia prior to starting hemodialysis (HD) were more likely to die despite achieving target hemoglobin levels at month 4 after HD initiation.
Reducing PTH Might Improve Anemia in Hemodialysis
Anemia control may be one more reason to treat elevated parathyroid hormone levels.
FGF23 Predicts Development of CKD Anemia
Anemia is 66% and 84% more likely to develop among patients in the 3rd and 4th quartiles of serum fibroblast growth factor 23 level vs those in the 1st quartile.
FDA Approves 'Biosimilar' Drug to Treat Certain Types of Anemia
Retacrit is biosimilar to the drugs Epogen and Procrit.
Change in Red Blood Cell Distribution Width Tied With Mortality in HD
In a study, increases in red blood cell distribution width during the first year of dialysis was associated with greater risks for death.
Vadadustat Maintains Hemoglobin Levels in Hemodialysis Patients
Patients' mean hemoglobin levels stayed relatively stable after converting from an erythropoiesis-stimulating agent to the investigational drug.
No Reduction in Platelets Found With IV Iron Use in CKD
New study shows that IV iron repletion with sodium ferric gluconate complex increased platelet count significantly at week 3 post-infusion and non-significantly at week 4.
FDA Updates Triferic Label With New Safety Warning
Clinicians should advise women who could become pregnant to use effective contraception before and after taking the anemia drug.